Camford Capital

Camford Capital is a Palo Alto-based venture capital firm that focuses on investing in transformative technologies across sectors like enterprise software, consumer products, fintech, and healthcare. Founded in 2021, the firm partners with early-stage and growth-stage companies in the U.S. and Asia, seeking to back innovative solutions that have the potential to reshape industries globally. Camford has built a strong portfolio that includes notable investments such as CG Oncology and Totus Medicines, which highlight its emphasis on life sciences. Additionally, the firm has backed Viz.ai an AI-driven healthcare company, and Stori, a fintech unicorn offering credit card solutions in Latin America. The firm is particularly known for its ability to identify and support companies that leverage exponential technologies to tackle complex problems in healthcare and financial services. The leadership team at Camford consists of experienced entrepreneurs and investors, including Andrew Gu and Ali Farahanchi, who bring deep operational and investment expertise. Their strategy combines hands-on partnership with founders and an ability to co-invest with global players like General Catalyst and Khosla Ventures. Camford Capital tends to invest anywhere between $500,000 and $10 million, with a preference for leading funding rounds. Entrepreneurs seeking investment can reach out to the firm through its website for inquiries.